Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors.
暂无分享,去创建一个
Jaesung Park | Dong-Sic Choi | Su Chul Jang | Oh Youn Kim | Yong Song Gho | Jan Lötvall | Tae-Young Roh | Tae-Young Roh | J. Lötvall | Jaesung Park | Y. Gho | Yoon-Keun Kim | J. Nilsson | S. Jang | Yoon-Keun Kim | O. Y. Kim | Dong-Sic Choi | C. Yoon | Chang Min Yoon | Jonas Nilsson
[1] Jaesung Park,et al. Three-Dimensional Imaging of Hepatic Sinusoids in Mice Using Synchrotron Radiation Micro-Computed Tomography , 2013, PloS one.
[2] Y. Gho,et al. Proteomics, transcriptomics and lipidomics of exosomes and ectosomes , 2013, Proteomics.
[3] Jonathan D. Ashley,et al. A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes. , 2013, ACS nano.
[4] J. Lötvall,et al. EVpedia: an integrated database of high-throughput data for systemic analyses of extracellular vesicles , 2013, Journal of extracellular vesicles.
[5] Shinobu Ueda,et al. Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[6] Hu Yang,et al. Hybrid dendrimer hydrogel/PLGA nanoparticle platform sustains drug delivery for one week and antiglaucoma effects for four days following one-time topical administration. , 2012, ACS nano.
[7] R. Schiffelers,et al. Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[8] Per Sunnerhagen,et al. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes , 2012, Nucleic acids research.
[9] Yang You,et al. Anti-atherosclerotic function of Astragali Radix extract: downregulation of adhesion molecules in vitro and in vivo , 2012, BMC Complementary and Alternative Medicine.
[10] Ick Chan Kwon,et al. Multifunctional nanoparticles for multimodal imaging and theragnosis. , 2012, Chemical Society reviews.
[11] E. Choi,et al. Immunocytes as a biocarrier to delivery therapeutic and imaging contrast agents to tumors , 2012 .
[12] D. Cheresh,et al. Tumor angiogenesis: molecular pathways and therapeutic targets , 2011, Nature Medicine.
[13] M. Wood,et al. Exosome nanotechnology: An emerging paradigm shift in drug delivery , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.
[14] Dongmei Sun,et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[15] Hamid Cheshmi. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .
[16] M. Wood,et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.
[17] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[18] D. Hallahan,et al. Tumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[19] I. Melero,et al. Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytes. , 2011, Cancer research.
[20] Sébastien Lecommandoux,et al. Doxorubicin loaded magnetic polymersomes: theranostic nanocarriers for MR imaging and magneto-chemotherapy. , 2011, ACS Nano.
[21] Dongmei Sun,et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[22] J. Kim,et al. A membranous form of ICAM-1 on exosomes efficiently blocks leukocyte adhesion to activated endothelial cells. , 2010, Biochemical and biophysical research communications.
[23] Michael Schmidt,et al. Structural-mechanical characterization of nanoparticle exosomes in human saliva, using correlative AFM, FESEM, and force spectroscopy. , 2010, ACS nano.
[24] Daehee Hwang,et al. Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells , 2009, BMC Genomics.
[25] J. Bartek,et al. The DNA-damage response in human biology and disease , 2009, Nature.
[26] P. Wen,et al. Neurological adverse effects caused by cytotoxic and targeted therapies , 2009, Nature Reviews Clinical Oncology.
[27] C. Théry,et al. Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.
[28] Robert Langer,et al. Impact of nanotechnology on drug delivery. , 2009, ACS nano.
[29] Mark E. Davis,et al. Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.
[30] Milan Makale,et al. Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis , 2008, Proceedings of the National Academy of Sciences.
[31] Jiri Bartek,et al. An Oncogene-Induced DNA Damage Model for Cancer Development , 2008, Science.
[32] Mauro Ferrari,et al. Nanogeometry: beyond drug delivery. , 2008, Nature nanotechnology.
[33] H. Kwon,et al. Proteomic analysis of microvesicles derived from human colorectal cancer cells. , 2007, Journal of proteome research.
[34] M. Cybulsky,et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated , 2007, Nature Reviews Immunology.
[35] D. Michod,et al. DNA-damage sensitizers: potential new therapeutical tools to improve chemotherapy. , 2007, Critical reviews in oncology/hematology.
[36] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[37] S. Wise. Nanocarriers as an emerging platform for cancer therapy , 2007 .
[38] J Ratajczak,et al. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication , 2006, Leukemia.
[39] William E. Grizzle,et al. Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function1 , 2006, The Journal of Immunology.
[40] Napoleone Ferrara,et al. Angiogenesis as a therapeutic target , 2005, Nature.
[41] Gert Storm,et al. Coformulated N-Octanoyl-glucosylceramide Improves Cellular Delivery and Cytotoxicity of Liposomal Doxorubicin , 2005, Journal of Pharmacology and Experimental Therapeutics.
[42] K. Shedden,et al. Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. , 2003, Cancer research.
[43] H. Kleinman,et al. Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. , 2002, Cancer research.
[44] R. Ho,et al. Trends and developments in liposome drug delivery systems. , 2001, Journal of pharmaceutical sciences.
[45] Shaoyu Zhou,et al. Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin. , 2001, Cancer research.
[46] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[47] YuqingHuo,et al. Role of Vascular Cell Adhesion Molecule-1 and Fibronectin Connecting Segment-1 in Monocyte Rolling and Adhesion on Early Atherosclerotic Lesions , 2000 .
[48] H. Maeda,et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[49] H. Kleinman,et al. Angiogenic activity of human soluble intercellular adhesion molecule-1. , 1999, Cancer research.
[50] S. Sebti,et al. Antitumor efficacy of a novel class of non-thiol-containing peptidomimetic inhibitors of farnesyltransferase and geranylgeranyltransferase I: combination therapy with the cytotoxic agents cisplatin, Taxol, and gemcitabine. , 1999, Cancer research.
[51] D. Adams,et al. Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor-infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma. , 1998, Journal of immunology.
[52] M. Labow,et al. Cytokine induction of an alternatively spliced murine vascular cell adhesion molecule (VCAM) mRNA encoding a glycosylphosphatidylinositol-anchored VCAM protein. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[53] H. Loetscher,et al. Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55 , 1993, The Journal of experimental medicine.
[54] Michael Loran Dustin,et al. On the species specificity of the interaction of LFA-1 with intercellular adhesion molecules. , 1990, Journal of immunology.